Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain

F B Meyer1, L M Bates, S J Goerss

  • 1Department of Neurologic Surgery, Mayo Clinic, Rochester, Minn 55905, USA. meyer.fredric@mayo.edu

Abstract

Insights

Awake brain surgery using frameless stereotaxis and real-time monitoring allows maximal glial tumor resection in eloquent areas. This approach enables good functional recovery by stopping resection at the onset of neurologic deficits.

Area of Science:

  • Neurosurgery
  • Oncology
  • Neurology

Background:

  • Resection of glial tumors in eloquent brain regions poses challenges due to the risk of postoperative neurologic deficits.
  • Maximal safe tumor resection is crucial for improving patient outcomes and survival.

Purpose of the Study:

  • To evaluate the feasibility of maximal tumor resection with acceptable neurologic dysfunction using awake stereotactic glial tumor resection.
  • To assess functional outcomes after awake craniotomy for brain tumors.

Main Methods:

  • 65 patients with glial tumors in eloquent areas underwent frameless stereotactic resection.
  • Intraoperative neurologic and language monitoring was performed continuously by a neurologist and speech pathologist.
  • Novel segmentation software measured tumor volume reduction from pre- and postoperative MRI.

Main Results:

  • 52% of patients achieved >90% T2 signal reduction postoperatively.
  • 74% experienced intraoperative deficits, but 71% recovered to a modified Rankin grade of 0 or 1 at 3 months.
  • No operative mortality occurred; 26% died from tumor progression during follow-up.

Conclusions:

  • Frameless stereotaxis combined with intraoperative monitoring facilitates maximal tumor resection in eloquent brain regions.
  • Resection guided by neurologic deficits allows for good functional recovery.
  • Imaging software accurately quantifies tumor resection volumes.

Related Concept Videos